Home › Breast Cancer › California › Pasadena
Breast Cancer clinical trials in Pasadena, CA
4 studies for Breast Cancer are looking for participants at sites in and around Pasadena (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecruitingPhase 3
- Huntington Memorial Hospital, Pasadena
- Keck Medical Center of USC Pasadena, Pasadena
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RecruitingPhase 3
- Los Angeles Cancer Network_Pasadena, Pasadena
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
RecruitingPhase 2
- CS Cancer at Huntington Cancer Center, Pasadena
Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Recruiting
- KP Southern California - Department of Research & Evaluation, Pasadena
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY134 studies
- Houston, TX126 studies
- Boston, MA111 studies
- Nashville, TN80 studies
- Los Angeles, CA72 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Durham, NC63 studies
- Queens, NY63 studies
- Chicago, IL58 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Other studies in Pasadena
- Steatotic Liver Disease8 studies
- Atrial Fibrillation4 studies
- Macular Edema3 studies
- Blood Clots3 studies
- Macular Degeneration3 studies
- Heart Failure3 studies
- Myasthenia Gravis3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.